Literature DB >> 11673094

Quantification of early blood-brain barrier disruption by in situ brain perfusion technique.

A K Bhattacharjee1, T Nagashima, T Kondoh, N Tamaki.   

Abstract

Osmotic disruption is currently being used to circumvent the blood-brain barrier (BBB) and enhance the delivery of therapeutic molecules in human brains. To date, however, the time course during the early phase of disruption has not been clarified. In order to demonstrate the rapid change in cerebrovascular permeability after BBB disruption in rats, we developed a method of in situ brain perfusion to demonstrate the earliest reversibility in cerebrovascular permeability. Osmotic BBB disruption was attained by intracarotid infusion of hypertonic mannitol. Perfusate containing [14C]-sucrose was infused at different time points following osmotic stress followed by measuring cerebrovascular permeability. The earliest BBB disruption was seen to occur 5 min after osmotic stress, after which the exact time course of cerebrovascular reversibility was studied. The protocol reported here, in contrast with those reported in previous studies, was shown to be qualitative, simple, and fast. In addition, the method can be applied to measure any low BBB permeability molecules. This protocol should be helpful for any research focused on enhancing drug delivery into the brain following osmotic BBB disruption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673094     DOI: 10.1016/s1385-299x(01)00094-0

Source DB:  PubMed          Journal:  Brain Res Brain Res Protoc        ISSN: 1385-299X


  16 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

2.  Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells.

Authors:  Rachel C Brown; Andrew P Morris; Roger G O'Neil
Journal:  Brain Res       Date:  2006-12-12       Impact factor: 3.252

Review 3.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Morphine facilitates doxorubicin penetration in the central nervous system: a new prospect for therapy of brain tumors.

Authors:  Iacopo Sardi
Journal:  J Neurooncol       Date:  2011-01-14       Impact factor: 4.130

5.  Impact of drug size on brain tumor and brain parenchyma delivery after a blood-brain barrier disruption.

Authors:  Marie Blanchette; Luc Tremblay; Martin Lepage; David Fortin
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-12       Impact factor: 6.200

6.  Real-time hemodynamic response and mitochondrial function changes with intracarotid mannitol injection.

Authors:  Shailendra Joshi; Rajinder Singh-Moon; Mei Wang; Jeffrey N Bruce; Irving J Bigio; Avraham Mayevsky
Journal:  Brain Res       Date:  2014-01-15       Impact factor: 3.252

7.  Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation.

Authors:  Jeffrey J Lochhead; Gwen McCaffrey; Colleen E Quigley; Jessica Finch; Kristin M DeMarco; Nicole Nametz; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

8.  Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain.

Authors:  Jeffrey J Lochhead; Gwen McCaffrey; Lucy Sanchez-Covarrubias; Jessica D Finch; Kristin M Demarco; Colleen E Quigley; Thomas P Davis; Patrick T Ronaldson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-11       Impact factor: 4.733

9.  Regional distribution of SGLT activity in rat brain in vivo.

Authors:  Amy S Yu; Bruce A Hirayama; Gerald Timbol; Jie Liu; Ana Diez-Sampedro; Vladimir Kepe; Nagichettiar Satyamurthy; Sung-Cheng Huang; Ernest M Wright; Jorge R Barrio
Journal:  Am J Physiol Cell Physiol       Date:  2012-11-14       Impact factor: 4.249

10.  Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain.

Authors:  Patrick T Ronaldson; Kristin M Demarco; Lucy Sanchez-Covarrubias; Christine M Solinsky; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-25       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.